- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07649590
Diagnostic Value of Strain Elastography in Characterization of Solid Breast Lesions.
Breast lesions are a common concern in clinical practice, requiring accurate diagnostic tools for effective evaluation. Traditional imaging modalities, such as mammography and ultrasound, play critical roles in detecting and characterizing these lesions. However, the emergence of advanced techniques like strain elastography has significantly enhanced our ability to assess the mechanical properties of breast tissues, providing valuable insights beyond standard imaging. Strain elastography is a non-invasive ultrasound-based technique that evaluates tissue stiffness by measuring the degree of deformation in response to applied pressure. This technique capitalizes on the principle that malignant tissues are typically stiffer than benign ones, offering a potential method for differentiating between solid breast lesions. By assessing the elastic properties of breast tissues, strain elastography aids in improving diagnostic accuracy and reducing the need for unnecessary biopsies.
The diagnostic value of strain elastography lies in its ability to provide real-time feedback during ultrasound examinations. This immediacy allows clinicians to make informed decisions about further management based on the mechanical characteristics of the lesions. The integration of strain elastography into routine breast imaging protocols can enhance the specificity and sensitivity of lesion characterization, ultimately benefiting patient outcomes.
Studieoversikt
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
-
Sohag, Egypt
- Sohag university hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
Tar imot friske frivillige
Prøvetakingsmetode
Studiepopulasjon
Woman aged 18 years or older.
- Having solid breast lesions identified through mammography or ultrasound and who are scheuduled for biopsy
Beskrivelse
Inclusion Criteria:
- Woman aged 18 years or older.
- Having solid breast lesions identified through mammography or ultrasound and who are scheuduled for biopsy
Exclusion Criteria:
- Patient with proor breast surgeries
- patient who had alocalzied systemic diseases that prevents biopsy.
- Inflammtory conditions
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Assessment of the mass harness by elastography
Tidsramme: one year
|
assessmnet of the mass harness by elasography ration E2/E1
|
one year
|
Samarbeidspartnere og etterforskere
Sponsor
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Cantisani V, David E, Barr RG, Radzina M, de Soccio V, Elia D, De Felice C, Pediconi F, Gigli S, Occhiato R, Messineo D, Fresilli D, Ballesio L, D'Ambrosio F. US-Elastography for Breast Lesion Characterization: Prospective Comparison of US BIRADS, Strain Elastography and Shear wave Elastography. Ultraschall Med. 2021 Oct;42(5):533-540. doi: 10.1055/a-1134-4937. Epub 2020 Apr 24.
- Li X, Sun W, Zhang H. The value of elastography strain rate ratio in benign and malignant BI-RADS-US 3-4 breast masses. Biomol Biomed. 2024 May 2;24(3):625-632. doi: 10.17305/bb.2023.9878.
- Mutala TM, Mwango GN, Aywak A, Cioni D, Neri E. Determining the elastography strain ratio cut off value for differentiating benign from malignant breast lesions: systematic review and meta-analysis. Cancer Imaging. 2022 Feb 12;22(1):12. doi: 10.1186/s40644-022-00447-5.
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- Sog-Med--24-12-08MS
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .